Development of biliary stent applying the antibacterial activity of silver: A literature review.


Journal

Bio-medical materials and engineering
ISSN: 1878-3619
Titre abrégé: Biomed Mater Eng
Pays: Netherlands
ID NLM: 9104021

Informations de publication

Date de publication:
2021
Historique:
pubmed: 16 3 2021
medline: 31 8 2021
entrez: 15 3 2021
Statut: ppublish

Résumé

Endoscopic transpapillary stenting is commonly performed in patients with obstructive jaundice caused by a biliary stricture. Although the plastic stent (PS) is widely used for biliary drainage because of the low-cost and easy procedure, patency is short after placement in the bile duct because of the small diameter. Dysfunction of PS is primarily caused by biliary sludge that forms as a result of bacterial adhesion and subsequent biofilm formation on the inner surface of the stent. It is well known that silver ions have excellent antibacterial activity against a wide range of microorganisms. This review provides an overview and perspective of the significance of silver-coated biliary stents. We collected literature regarding silver-coated biliary stents, reviewed the current research/development status and discussed their possible usefulness. To date, several in vivo/vitro studies evaluated the patency of silver-blended or silver-coated biliary stents. These studies suggested that the silver coating on a PS was likely to prolong the patency period. The development of biliary stents using silver is expected to prolong stent patency and prevent frequent stent replacement.

Sections du résumé

BACKGROUND BACKGROUND
Endoscopic transpapillary stenting is commonly performed in patients with obstructive jaundice caused by a biliary stricture. Although the plastic stent (PS) is widely used for biliary drainage because of the low-cost and easy procedure, patency is short after placement in the bile duct because of the small diameter. Dysfunction of PS is primarily caused by biliary sludge that forms as a result of bacterial adhesion and subsequent biofilm formation on the inner surface of the stent. It is well known that silver ions have excellent antibacterial activity against a wide range of microorganisms.
OBJECTIVE OBJECTIVE
This review provides an overview and perspective of the significance of silver-coated biliary stents.
METHODS METHODS
We collected literature regarding silver-coated biliary stents, reviewed the current research/development status and discussed their possible usefulness.
RESULTS RESULTS
To date, several in vivo/vitro studies evaluated the patency of silver-blended or silver-coated biliary stents. These studies suggested that the silver coating on a PS was likely to prolong the patency period.
CONCLUSION CONCLUSIONS
The development of biliary stents using silver is expected to prolong stent patency and prevent frequent stent replacement.

Identifiants

pubmed: 33720871
pii: BME201163
doi: 10.3233/BME-201163
doi:

Substances chimiques

Anti-Bacterial Agents 0
Silver 3M4G523W1G

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

63-71

Auteurs

Akane Yamabe (A)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Atsushi Irisawa (A)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Yasuhito Kunogi (Y)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Ken Kashima (K)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Kazunori Nagashima (K)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Takahito Minaguchi (T)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Akira Yamamiya (A)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Naoya Izawa (N)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Yoichi Takimoto (Y)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Koki Hoshi (K)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Lisa Nonaka (L)

Department of Nutritional Science, Faculty of Human Life Science, Shokei University, Kumamoto, Japan.

Michiaki Masuda (M)

Department of Microbiology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Keiichi Tominaga (K)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Kenichi Goda (K)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Makoto Iijima (M)

Department of Gastroenterology, Dokkyo Medical University School of Medicine, Mibu, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH